Date & Time
Thursday, November 19, 2026 | Noon ET / 11 a.m. CT
Join the Coalition Against Childhood Cancer (CAC2) for a timely discussion of the post-election landscape and opportunities to advance policies that support children with cancer, survivors, and their families.
Childhood cancer advocates and physician leaders will discuss federal legislative priorities, opportunities to engage newly elected members of Congress, and practical ways to strengthen the community’s collective voice. The program will also introduce Golden Thread’s proposed legislation to reduce barriers to treating children with cancer across state lines.
Planned discussion topics include:
- Federal priorities, including OMB rules, the Lainie Jones Comprehensive Cancer Survivorship Act, and Kylie’s Voices for Childhood Cancer Act.
- The post-election landscape and opportunities for congressional outreach.
- Engagement with the Congressional Childhood Cancer Caucus.
- Golden Thread’s proposed legislation addressing access to care across state lines.
- Advocacy tools and resources to support outreach, relationship-building, and community participation.
SPEAKERS
Steve Wosahla
Chief Executive Officer, Children’s Cancer Cause
Steve Wosahla leads Children’s Cancer Cause’s strategy, operations, and policy advocacy to improve treatment and quality of life for children with cancer and their families. He works with Congress, federal agencies, and state governments and helps families participate in the policy process. His background includes executive leadership roles with the American Cancer Society and other national health organizations.
Ann Ramer, MPH
Chair Elect, Coalition Against Childhood Cancer
Ann Ramer is an experienced childhood cancer advocate whose work spans local, state, and national policy. A mother of four, including two children who developed multiple forms of cancer, she brings a family perspective to advocacy. Through CAC2, she helps connect advocates with resources and opportunities to strengthen engagement and improve outcomes for children and adolescents with cancer.
Michael “Mike” Henry
Senior Director of Advocacy, Pediatric Brain Tumor Foundation
Mike Henry leads advocacy efforts at the Pediatric Brain Tumor Foundation, working to make childhood brain cancer a national priority. His commitment is deeply personal: his daughter Blair died from brain cancer in 2020 at age three. With a background in nonprofit policy and fundraising, Mike advocates for improved outcomes and support for families affected by pediatric brain tumors.
Ashley Margol, MD, MS
Co-Founder, Golden Thread
Director, Brain Tumor Center and Neuro-Oncology Program, Children’s Hospital Los Angeles
Dr. Ashley Margol is a pediatric neuro-oncologist and Associate Professor of Clinical Pediatrics at USC’s Keck School of Medicine. She specializes in treating young children with brain tumors and co-leads the Pediatric Neuro-Oncology Consortium. Through her clinical research and work with Golden Thread, she develops new treatment approaches and addresses barriers to pediatric cancer care.
Cassie Kline, MD, MAS
Co-Founder, Golden Thread
Director of Neuro-Oncology Clinical Research, Children’s Hospital of Philadelphia
Dr. Cassie Kline is a pediatric neuro-oncologist whose work focuses on clinical trial innovation, new therapies, and health equity in pediatric oncology. She co-leads the Pediatric Neuro-Oncology Consortium and clinical trials for children with difficult-to-treat brain tumors. She co-founded Golden Thread to help remove systemic barriers to research and care.
Misha Mehta, PhD
Senior Director of Research, Pediatric Brain Tumor Foundation
Dr. Misha Mehta is a scientist, patient advocate, and Co-Founder and President of the Neev Kolte Foundation. Following the loss of her son, Neev, to DIPG, she dedicated her work to advancing childhood cancer research, strengthening advocacy, and improving outcomes
